Sixteen faculty and professional staff members in state contract colleges at Cornell are receiving the 2019-20 State University of New York Chancellor’s Awards for Excellence.
Bacteria are growing increasingly antibiotic-resistant, but new research reveals how certain enzymes could be exploited to develop new classes of drugs to fight bacterial infections.
Cornell researchers combined genetic engineering, single-molecule tracking and protein quantitation to get a closer look at how living bacteria identify – and then build resistance to – toxic chemicals and metals. The knowledge could lead to the development of more effective antibacterial treatments.
The commercialization of a Cornell-created antimicrobial coating technology that keeps surfaces clean by extending the life of chlorine-based disinfectants – by days and even weeks – is being fast-tracked to determine how well it can combat COVID-19.
The prospect of residency typically brings jitters to newly minted doctors, but the transition has become far more complex with numerous unknowns surrounding the ongoing COVID-19 pandemic.
Students reflected on their learning experiences and future goals in community engagement as they completed a leadership certificate program this spring.
The Cornell High Energy Synchrotron Source will partially restart operations in June to conduct research related to treatment of SARS-CoV-2, the virus that causes COVID-19.
